Alamar Biosciences, Inc. (ALMR) Reports Q2 Loss of $0.22 Aug 10, 2026 05:15PM
Alamar Biosciences expands Alzheimer's proteomics deal to 140,000 samples Aug 10, 2026 04:04PM
Alamar Biosciences launches immune profiling panel measuring 340 proteins Jul 28, 2026 04:12PM
Alamar Biosciences launches national Alzheimer's proteomics study Jul 13, 2026 05:43AM
Alamar Biosciences NULISA data to appear in 140+ AAIC presentations Jul 10, 2026 06:13AM


Jul 7, 2026 09:12AM Alamar Biosciences launches eMTBR-Tau blood test for Alzheimer's
Jun 9, 2026 09:08AM Stifel Reiterates Buy Rating on Alamar Biosciences (ALMR)
May 12, 2026 06:22AM BofA Securities Resumes Alamar Biosciences (ALMR) at Neutral
May 12, 2026 05:29AM TD Cowen Starts Alamar Biosciences (ALMR) at Buy
May 12, 2026 03:16AM JPMorgan Starts Alamar Biosciences (ALMR) at Overweight
May 12, 2026 01:06AM Stifel Starts Alamar Biosciences (ALMR) at Buy
Apr 16, 2026 10:54AM Alamar Biosciences IPO expected to price at top of range or above
Apr 13, 2026 06:11AM Alamar Biosciences files 9.375M share IPO at $15-$17/sh
Mar 27, 2026 04:19PM Alamar Biosciences files for proposed Nasdaq IPO